INNO-LiPA HLA-DQB1 Update - Taiwan Registration f464bf018452f4048cf71726259f3a48

Access comprehensive regulatory information for INNO-LiPA HLA-DQB1 Update in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f464bf018452f4048cf71726259f3a48 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.